Simple gel may prevent painful side effect of liver cancer drug
NCT ID NCT07560566
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests if applying a topical gel (indomethacin) to the hands before starting sorafenib can prevent or reduce hand-foot skin reactions, a common and painful side effect. About 39 adults with advanced liver cancer will use the gel twice daily for up to 12 weeks. The goal is to see if this simple approach helps patients stay on their cancer treatment with less discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAND FOOT SKIN SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Taiwan University Hospital
RECRUITINGTaipei, 10002, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common anesthetic help prevent liver cancer from coming back?
- New drug shows promise for tough liver cancer cases
- New combo therapy aims to shrink advanced liver and kidney tumors
- New combo therapy aims to slash liver cancer recurrence after surgery
- Can a Pre-Surgery immune boost stop liver Cancer's return?
- Liver cancer trial adds a resistance-blocker to standard chemo โ could it boost success?